{"id":"https://openalex.org/W7127044659","doi":"https://doi.org/10.1158/0008-5472.c.8284911","title":"Data from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer","display_name":"Data from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer","publication_year":2026,"publication_date":"2026-02-02","ids":{"openalex":"https://openalex.org/W7127044659","doi":"https://doi.org/10.1158/0008-5472.c.8284911"},"language":null,"primary_location":{"id":"doi:10.1158/0008-5472.c.8284911","doi":"https://doi.org/10.1158/0008-5472.c.8284911","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.8284911","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.8284911","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016814827","display_name":"Jean-David Fumet","orcid":"https://orcid.org/0000-0002-9444-941X","observed_orcids":["https://orcid.org/0000-0002-9444-941X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-David Fumet","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9444-941X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124732219","display_name":"Charl\u00e8ne Latour","orcid":"https://orcid.org/0009-0004-5925-7748","observed_orcids":["https://orcid.org/0009-0004-5925-7748"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charl\u00e8ne Latour","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-5925-7748","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077546174","display_name":"Lisa Nuttin","orcid":"https://orcid.org/0009-0002-2634-4787","observed_orcids":["https://orcid.org/0009-0002-2634-4787"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Nuttin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-2634-4787","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124700538","display_name":"Valentin Derang\u00e8re","orcid":"https://orcid.org/0000-0002-6311-5628","observed_orcids":["https://orcid.org/0000-0002-6311-5628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentin Derang\u00e8re","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6311-5628","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124697700","display_name":"Alis Ilie","orcid":"https://orcid.org/0009-0009-5788-1586","observed_orcids":["https://orcid.org/0009-0009-5788-1586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alis Ilie","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-5788-1586","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124729961","display_name":"Pauline Russo","orcid":"https://orcid.org/0009-0002-0656-5662","observed_orcids":["https://orcid.org/0009-0002-0656-5662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Russo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-0656-5662","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073726846","display_name":"L\u00e9a Hampe","orcid":"https://orcid.org/0009-0005-5996-6306","observed_orcids":["https://orcid.org/0009-0005-5996-6306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L\u00e9a Hampe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5996-6306","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124729692","display_name":"Susy Daumoine","orcid":"https://orcid.org/0009-0003-9585-653X","observed_orcids":["https://orcid.org/0009-0003-9585-653X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susy Daumoine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-9585-653X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085250039","display_name":"Marion Thibaudin","orcid":"https://orcid.org/0000-0002-1046-5982","observed_orcids":["https://orcid.org/0000-0002-1046-5982"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marion Thibaudin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1046-5982","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011315376","display_name":"Caroline Truntzer","orcid":"https://orcid.org/0000-0003-0895-4813","observed_orcids":["https://orcid.org/0000-0003-0895-4813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Truntzer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0895-4813","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043463827","display_name":"Fran\u00e7ois Ghiringhelli","orcid":"https://orcid.org/0000-0002-5465-8305","observed_orcids":["https://orcid.org/0000-0002-5465-8305","https://orcid.org/0009-0000-3637-9479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois Ghiringhelli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5465-8305","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018585640","display_name":"Emeric Limagne","orcid":"https://orcid.org/0000-0002-1098-8441","observed_orcids":["https://orcid.org/0000-0002-1098-8441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emeric Limagne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1098-8441","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0272000003606081,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microsatellite-stable-colorectal-cancer","display_name":"microsatellite stable colorectal cancer","score":0.906000018119812},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8669999837875366},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cd8-t-cell-exhaustion","display_name":"CD8+ T cell exhaustion","score":0.8690000176429749},{"id":"https://openalex.org/keywords/tigit","display_name":"TIGIT","score":0.7820000052452087},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.8209999799728394},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7440000176429749},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C2779118045","wikidata":"https://www.wikidata.org/wiki/Q21114021","display_name":"TIGIT","level":4,"score":0.9794999957084656},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6704999804496765},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6581000089645386},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6581000089645386},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6162999868392944},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5361999869346619},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5037000179290771},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5001000165939331},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.46129998564720154},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4551999866962433},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3684999942779541},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34790000319480896},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3449000120162964},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.34459999203681946},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.32510000467300415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3190999925136566},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.30410000681877136},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2854999899864197},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.27639999985694885},{"id":"https://openalex.org/C11988809","wikidata":"https://www.wikidata.org/wiki/Q412889","display_name":"Interleukin 6","level":3,"score":0.27250000834465027},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.2685000002384186},{"id":"https://openalex.org/C2777956040","wikidata":"https://www.wikidata.org/wiki/Q416554","display_name":"Prostaglandin E2","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2662999927997589},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.2630000114440918},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.25870001316070557}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.8284911","doi":"https://doi.org/10.1158/0008-5472.c.8284911","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.8284911","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.8284911","doi":"https://doi.org/10.1158/0008-5472.c.8284911","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.8284911","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6051948666572571}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Immune":[1],"checkpoint":[2,276],"blockade":[3,277],"treatment":[4],"is":[5],"highly":[6],"effective":[7],"in":[8,44,112,133,167,169,196,217,222,234,238,259],"microsatellite-instable":[9],"(MSI)":[10],"colorectal":[11,22,45,209,240,260],"cancer.":[12,261],"However,":[13],"microsatellite-stable":[14,271],"(MSS)":[15],"tumors,":[16,78],"which":[17],"represent":[18],"95%":[19],"of":[20,39,52,158,230,246,282],"metastatic":[21],"cancer,":[23],"are":[24],"intrinsically":[25],"resistant":[26],"to":[27,34,41,274],"immunotherapy.":[28],"In":[29,76,106],"this":[30],"study,":[31],"we":[32],"sought":[33],"better":[35],"understand":[36],"the":[37,49,70,212,228,231,244,280],"mechanisms":[38],"resistance":[40],"anti\u2013PD-L1":[42,248],"therapy":[43,249],"cancer":[46,210,241],"by":[47,267,278],"characterizing":[48],"immune":[50,275],"profiles":[51],"MSS":[53,77,170,239],"and":[54,67,85,88,92,102,119,123,136,155,177,186,202,220,242],"MSI":[55,113,134,174],"tumor":[56,60],"models.":[57],"Although":[58],"both":[59],"types":[61],"presented":[62],"intratumoral":[63],"CD8+":[64,72,80,109,142,152,188,197,218,287],"T-cell":[65,73,86,143,153,189,219],"responses":[66],"PD-L1":[68,159,236],"expression,":[69,150],"exhausted":[71,79,96,284],"phenotypes":[74],"differed.":[75],"T":[81,110,198,288],"cells":[82,111],"coexpressed":[83],"PD-1":[84],"immunoglobulin":[87],"ITIM":[89],"domain":[90],"(TIGIT)":[91],"exhibited":[93],"a":[94],"terminal":[95],"profile":[97],"with":[98,139,173,208,250],"low":[99],"cytokine":[100,122],"secretion":[101],"limited":[103],"cytotoxic":[104,124],"function.":[105],"contrast,":[107],"PD-1+":[108,140,285],"tumors":[114,135,171,273],"did":[115],"not":[116],"express":[117],"TIGIT":[118,149,184,194,216,251],"displayed":[120],"higher":[121],"activities.":[125],"Interestingly,":[126],"immunosuppressive":[127],"M2-like":[128,145,256],"tumor-associated":[129,268],"macrophages":[130,269],"(TAM)":[131],"accumulated":[132],"positively":[137],"correlated":[138],"TIGIT+":[141,286],"frequency.":[144],"TAM":[146,232,257],"depletion":[147],"reduced":[148],"increased":[151],"function,":[154],"improved":[156],"efficacy":[157,237],"blockade.":[160],"Transcriptomic":[161],"analysis":[162],"revealed":[163],"elevated":[164,215],"COX1/2":[165,221],"expression":[166,185],"TAMs":[168],"compared":[172],"tumors.":[175],"COX2":[176],"prostaglandin":[178],"E2":[179],"(PGE2)":[180],"receptor":[181],"inhibition":[182,258],"impeded":[183],"restored":[187],"activity,":[190],"whereas":[191],"PGE2":[192,253,264],"triggered":[193],"upregulation":[195],"cells.":[199],"Single-cell,":[200],"spatial,":[201],"bulk":[203],"transcriptomic":[204],"data":[205,226],"from":[206],"patients":[207],"substantiated":[211],"correlation":[213],"between":[214],"TAMs.":[223],"Together,":[224],"these":[225],"uncover":[227],"role":[229],"axis":[233],"inhibiting":[235],"support":[243],"utility":[245],"combining":[247],"blockade,":[252],"treatment,":[254],"or":[255],"Significance:":[262],"Targeting":[263],"signaling":[265],"activated":[266],"sensitizes":[270],"colon":[272],"limiting":[279],"emergence":[281],"an":[283],"population.":[289]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2026-02-03T00:00:00"}